GZMB and COVID-19: NKG2A expression is upregulated on NK cells and CTLs in COVID-19 patients, with a decreased capacity to produce CD107a, IFN-γ, IL-2, granzyme B and TNF-α., which suggests functional exhaustion of cytotoxic lymphocytes in COVID-19 patients (160).